跳至主要内容
临床试验/NCT03332641
NCT03332641已完成不适用

A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on Improvement of Blood Cholesterol

Hanyang University2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2017年6月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
2
主要终点
Changes of Cholesterol

研究概览

简要总结

This study was conducted to investigate the effects of daily supplementation of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on improvement of Blood Cholesterol.

详细描述

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Twenty subjects were randomly divided into Citron(Citrus Junos Siebold ex Tanaka) Peel Extract or a placebo group. Blood cholesterol profiles before and after the intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 19-75 years with Total cholesterol 200-239 mg/dL

排除标准

  • Lipid lowering agent within past 6 months
  • Severe cardiovascular disease(Mvodardial infarction, stroke, etc)
  • Renal disease(Heredity hyperlipidemia, Acute/Chronic renal failure, Nephrotic syndrome, ect)
  • Cancer, Respiratory organ disease(Asthma, Chronic obstructive pulmonary disease)
  • Diabetes mellitus
  • Allergic or hypersensitive to any of the ingredients in the test products
  • History of disease that could interfere with the test products or impede their absorption
  • Under antipsychotic drugs therapy within past 2 months
  • History of alcohol or substance abuse
  • Participation in any other clinical trials within past 2 months
  • Laboratory test by show the following results
  • Pregnancy or breast feeding
  • Not Contraception(except: Surgery for female infertility)

研究组 & 干预措施

Citron peel Extract

Experimental

Citron peel extract for 12 weeks

干预措施: Citron peel extract (Dietary Supplement)

Placebo

Placebo Comparator

Placebo for 12 weeks

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Changes of Cholesterol

时间窗: 12 weeks

Changes of Cholesterol were assessed before and after the intervention

次要结局

  • Changes of Lipid profile(12 weeks)
  • Changes of Oxidized LDL(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yongsoon Park

Professor

Hanyang University

研究点 (2)

Loading locations...

相似试验